Structural

Current Clinical Evidence Following TR Interventions

20 min.

Can We Predict RV Failure After Tricuspid Intervention?

13 min.

Orthotopic TTVR: What Have We Learned From the EFS studies

14 min.

Quality of Life After Transcatheter Tricuspid-Valve Repair vs. Medical Therapy in Patients with Severe Tricuspid Regurgitation: Results From the Randomized TRILUMINATE Pivotal Trial

20 min.

TRISCEND II: A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients with Severe Tricuspid Regurgitation

22 min.

A Novel Single-Leaflet Tricuspid Valve Replacement System (Trisol): Early Clinical Results

7 min.

One-Month Outcomes of the Multicenter TRAVEL II (Transvascular Tricuspid Valve Replacement with the LuX-Valve Plus System) Study

9 min.

Safety and Efficacy of a Novel Vertical Spacer with Atraumatic Anchoring for Tricuspid Regurgitation: A First-in-Man Experience (Pivot Bridge)

12 min.

The CROIVALVE Duo System for the Percutaneous Treatment of Tricuspid Regurgitation: Technology and Program Update

13 min.

TRILUMINATE Pivotal Imaging Substudy: Insights from CT and MRI

13 min.

Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation: The Tri-QOL Study

13 min.

PROs are a Powerful Endpoint in TR Interventional Trials

8 min.

TRILUMINATE Pivotal: Outcomes of Both Randomized and Single-arm Subjects with Transcatheter Tricuspid Valve Edge-to-Edge Repair for Tricuspid Regurgitation

18 min.

Combining the Best of Tricuspid Valve Repair & Replacement (CroiValve)

5 min.

The CLASP II Trial: First 30-Day Procedural and Clinical Outcomes Report From the Roll-in Cohort

7 min.

Transcatheter Tricuspid Valve Replacement: Lessons Learned from Recent Clinical Trials

8 min.

Clinical Trial Data Supporting the Use of Tricuspid TEER in Symptomatic Severe TR Patients

8 min.

Clinical Benchmarks for Therapy Success in Transcatheter Tricuspid Therapy

9 min.